Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Srdan Verstovsek
Masitinib for Treatment of Severely Symptomatic Indolent Systemic Mastocytosis: A Randomised, Placebo-Controlled, Phase 3 Study
The Lancet
Medicine
Genes Involved in Maintaining the Bone Marrow Stroma Are Dysregulated in Patients With Myelofibrosis: Lenalidomide Treatment Upregulates SOCS3
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Long-Term Molecular and Cytogenetic Response and Survival Outcomes With Imatinib 400 Mg, Imatinib 800 Mg, Dasatinib, and Nilotinib in Patients With Chronic-Phase Chronic Myeloid Leukaemia: Retrospective Analysis of Patient Data From Five Clinical Trials
The Lancet Haematology
Hematology
Morphologic and Molecular Characteristics of De Novo AML WithJAK2V617F Mutation
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
A Multimodality Work-Up of Patients With Hypereosinophilia
American Journal of Hematology
Hematology
Prognostic Significance of Additional Chromosomal Abnormalities at the Time of Diagnosis in Patients With Chronic Myeloid Leukemia Treated With Frontline Tyrosine Kinase Inhibitors
American Journal of Hematology
Hematology
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-Controlled, Phase III Study in Patients With Myelofibrosis
British Journal of Haematology
Hematology
A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis
British Journal of Haematology
Hematology
Sensitive PCR-based Monitoring and Early Detection of Relapsed JAK2 V617F Myelofibrosis Following Transplantation
British Journal of Haematology
Hematology
1
2
3
4
›
